U.S. Renal Care's Geoffrey A. Block Honored with AAKP Medal of Excellence for Kidney Care Contributions

Dr. Geoffrey A. Block Receives AAKP Medal of Excellence

On May 13, 2026, a significant recognition took place in the healthcare sector as Dr. Geoffrey A. Block, the Associate Chief Medical Officer and Senior Vice President of Clinical Research and Medical Affairs at U.S. Renal Care, was honored with the prestigious 2026 American Association of Kidney Patients (AAKP) Medal of Excellence. This award stands as one of the highest accolades available for professionals dedicated to kidney health, reflecting his impactful career and longstanding commitment to enhancing the lives of individuals battling kidney disease.

Founded in 1969, the AAKP is the leading independent organization representing kidney patients in the United States. It aims to advocate for kidney patients, providing a platform to improve healthcare outcomes through innovation and patient choice. This medal is awarded to individuals who have significantly contributed to the improvement of kidney care nationally and internationally.

A Life of Dedication in Nephrology

Dr. Block's career is marked by over 30 years of remarkable achievements in the nephrology field. His groundbreaking work is characterized by an unwavering commitment to patient-centric care, advocacy, and clinical research. He has contributed to more than 140 peer-reviewed studies and has been instrumental in the development of transformative therapies for kidney disease.

His notable contributions include participating in several high-impact clinical trials and innovative therapies. He was among the first nephrologists to involve patients in critical clinical trials for therapies like Cinacalcet, Parsabiv®, and Tenapanor, which have changed the way kidney diseases are treated today. His extensive experience and leadership in clinical research underscore his influence on the nephrology landscape.

A Testament to Patient-Centric Care

Edward V. Hickey III, President of AAKP, emphasized Block's focus on patient interests, describing him as a leader who has bridged the gap between medical innovation and real-world patient outcomes.